GSK PLC AdrhedgedGSKHETF
13F holders, Q2 2025 (June 30)1holders −1
0new positions
1sold out
$52.56avg. 13F price*
At the end of Q2 2025, 1 institutions reported holding GSK PLC Adrhedged (GSKH) in their 13F filings, down 1 from Q1 2025. 0 opened new positions and 1 sold out. The largest holder was UBS Group AG ($7K).
- Company
- GSK PLC Adrhedged
- Filed as
- PRECIDIAN ETFS TR (Q2 2025)
- CUSIP
- 74016W874
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $961K |
All 13F filers, Q1 2025 → Q2 2025: 100 shares bought and 17,238 shares sold, net −17,138 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| UBS Group AG | 0.00% | Add +303.0% | 133 | $7K |
"% of holder's portfolio" is GSKH's weight in each manager's 13F, not the share of GSK PLC Adrhedged the manager owns.